USF Health is providing COVID-19 vaccinations to patients, employees and individuals in the community who meet eligibility criteria and as supply of vaccine permits. Learn More.
Dr. Kami Kim is a physician-scientist who joined the USF faculty in 2017 as a Professor of Internal Medicine (Infectious Diseases and International Medicine) and Professor of Global Health. Her laboratory focuses upon understanding the pathogenesis of toxoplasmosis and malaria, parasitic diseases of global significance. The Toxoplasma projects use a multidisciplinary systems biology approach to understand how the parasite senses and responds to changes in its host. Using a combination of epigenomics, genetics and proteomics, her group is studying how the parasite transitions from the pathogenic tachyzoite form to the persistent bradyzoite form. She is investigating the epigenetic and genetic factors that govern the host response to parasites.
Dr. Kim has worked with Plasmodium falciparum and Plasmodium yoelii, a rodent malaria, to develop new malaria drug treatments and to understand malaria virulence. More recently she has developed collaborations with clinical investigators at the Blantyre Malaria Project in Malawi to understand parasite and host factors that contribute to pathogenesis of severe malaria. She is also interested in the impact of HIV and other viral infections upon the clinical course of malaria.
In addition to running her laboratory, Dr. Kim is a practicing infectious diseases physician. She is a Section Editor for PloS Pathogens, Editor for International Journal of Infectious Diseases, Editor for the Sanford Guide for Antibiotic Therapy, a standing member of the NIH PTHE study section, and a member of the Scientific Advisory Board for the Burroughs Wellcome Fund Postdoctoral Enrichment Program. Her work is supported by the NIH.